Xellia Pharmaceuticals ApS (manufacturing of unpackaged product, primary packaging)
UkraineAll drugs from this manufacturer
-
The drug is used to treat severe infections caused by certain Gram-negative bacteria. It is also prescribed in inhalation form for the treatment of chronic pulmonary infections in patients with cystic fibrosis.
Dosage form: powder for solution for injection, infusion or inhalation
Active substance Dosage colistimethate sodium 1 000 000 IU ATC: J01XB01
-
The drug is used to treat severe infections caused by certain Gram-negative bacteria. It is also indicated for the treatment of chronic pulmonary infections in patients with cystic fibrosis.
Dosage form: powder for solution for injection, infusion or inhalation
Active substance Dosage colistimethate sodium 2 000 000 IU ATC: J01XB01